CompareMarketResearchRequest a sample
Home / Healthcare / Continuous Flow Bioreactors

Healthcare · Market report

Continuous Flow Bioreactors Market Size, Share and Forecast 2026-2036

The global continuous flow bioreactors market is worth USD 549 mn in 2026 and is forecast to reach USD 1.6 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Pilot and process development is the largest by scale segment.

USD 549 mnMarket size 2026
USD 1.6 bnForecast 2036
11.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global continuous flow bioreactors market is worth USD 549 mn in 2026 and is forecast to reach USD 1.6 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Pilot and process development is the largest by scale segment.

ScopeBioreactor systems that run cell culture with continuous perfusion or continuous feed and harvest, including single-use perfusion units, alternating tangential flow filters and controllers.
IndustryHealthcare
Value 2025USD 490 mn
Value 2026USD 549 mn
Value 2036USD 1.6 bn
CAGR 2026-203611.0%
Volume 20263,584 units
Volume 203610,176 units
Average price 2026USD 153,100 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Continuous Flow Bioreactors market size and forecast, 2026-2036

Exhibit 1The global continuous flow bioreactors market is forecast to grow from USD 549 mn in 2026 to USD 1.6 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 11.0%
Continuous Flow Bioreactors market value, 2025 to 2036Market value by year. 2025: USD 490 mn; 2026: USD 549 mn; 2027: USD 609 mn; 2028: USD 676 mn; 2029: USD 751 mn; 2030: USD 833 mn; 2031: USD 925 mn; 2032: USD 1.0 bn; 2033: USD 1.1 bn; 2034: USD 1.3 bn; 2035: USD 1.4 bn; 2036: USD 1.6 bn. Compound annual growth rate 2026 to 2036: 11.0%.2025549 mn2026925 mn20311.6 bn203611.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 549 mn
2027USD 609 mn
2028USD 676 mn
2029USD 751 mn
2030USD 833 mn
2031USD 925 mn
2032USD 1.0 bn
2033USD 1.1 bn
2034USD 1.3 bn
2035USD 1.4 bn
2036USD 1.6 bn

Continuous Flow Bioreactors market segmentation

By scale

Exhibit 2Pilot and process development is the largest segment by scale, with 38.0% of 2026 revenueEstimated share of 2026 global revenue, by scale
Continuous Flow Bioreactors market share by scale, 2026Share of 2026 revenue by scale. Pilot and process development: 38.0%; Clinical scale: 36.0%; Commercial scale: 26.0%.Pilot and process development38.0%Clinical scale36.0%Commercial scale26.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Pilot and process development38.0%34.5%USD 209 mn9.9%
Clinical scale36.0%37.3%USD 198 mn11.4%
Commercial scale26.0%28.2%USD 143 mn11.9%

By use

Exhibit 3Monoclonal antibodies adds the most revenue by use, growing from USD 241 mn in 2026 to USD 606 mn by 2036Estimated revenue in USD by use, 2026 and 2036 forecast
Continuous Flow Bioreactors market by use, 2026 and 2036Revenue by use in 2026 and 2036. Monoclonal antibodies: USD 241 mn in 2026, USD 606 mn in 2036, change +151%; Cell and gene therapy: USD 132 mn in 2026, USD 472 mn in 2036, change +259%; Viral vectors and vaccines: USD 110 mn in 2026, USD 315 mn in 2036, change +187%; Other biologics: USD 66 mn in 2026, USD 165 mn in 2036, change +151%.20262036 forecastChangeMonoclonal antibodies+151%241 mn606 mnCell and gene therapy+259%132 mn472 mnViral vectors and vaccines+187%110 mn315 mnOther biologics+151%66 mn165 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Monoclonal antibodies44.0%38.9%USD 241 mn9.6%
Cell and gene therapy24.0%30.3%USD 132 mn13.6%
Viral vectors and vaccines20.0%20.2%USD 110 mn11.1%
Other biologics12.0%10.6%USD 66 mn9.6%

By format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Single-use systems66.0%71.9%USD 362 mn11.9%
Hybrid systems12.0%11.4%USD 66 mn10.5%
Stainless steel systems22.0%16.7%USD 121 mn8.0%

By material

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Single use52.0%60.0%USD 285 mn12.6%
Stainless steel36.0%28.0%USD 198 mn8.2%
Glass and hybrid12.0%12.0%USD 66 mn11.0%

By application

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Monoclonal antibodies50.0%46.0%USD 274 mn10.1%
Vaccines20.0%17.0%USD 110 mn9.2%
Cell and gene therapy14.0%22.0%USD 77 mn16.1%
Others biologics16.0%15.0%USD 88 mn10.3%

Top 25 countries for continuous flow bioreactors by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 97.2%.

Exhibit 4United States is the largest country market at USD 198 mn in 2026, and the three largest countries hold 56.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Continuous Flow Bioreactors market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 198 mn, 36.0%; Germany: USD 55 mn, 10.0%; China: USD 55 mn, 10.0%; Switzerland: USD 33 mn, 6.0%; South Korea: USD 33 mn, 6.0%; Ireland: USD 27 mn, 5.0%; Japan: USD 27 mn, 5.0%; United Kingdom: USD 22 mn, 4.0%; Singapore: USD 22 mn, 4.0%; India: USD 19 mn, 3.5%.United States198 mn 36.0%Germany55 mn 10.0%China55 mn 10.0%Switzerland33 mn 6.0%South Korea33 mn 6.0%Ireland27 mn 5.0%Japan27 mn 5.0%United Kingdom22 mn 4.0%Singapore22 mn 4.0%India19 mn 3.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 198 mn36.0%USD 531 mn10.4%
2GermanyUSD 55 mn10.0%USD 142 mn10.0%
3ChinaUSD 55 mn10.0%USD 201 mn13.9%
4SwitzerlandUSD 33 mn6.0%USD 89 mn10.4%
5South KoreaUSD 33 mn6.0%USD 106 mn12.4%
6IrelandUSD 27 mn5.0%USD 73 mn10.3%
7JapanUSD 27 mn5.0%USD 67 mn9.3%
8United KingdomUSD 22 mn4.0%USD 59 mn10.4%
9SingaporeUSD 22 mn4.0%USD 67 mn11.8%
10IndiaUSD 19 mn3.5%USD 67 mn13.3%
11DenmarkUSD 7.3 mn1.3%USD 19 mn10.2%
12NetherlandsUSD 6.0 mn1.1%USD 16 mn10.3%
13BelgiumUSD 5.8 mn1.1%USD 15 mn10.2%
14SwedenUSD 4.4 mn0.8%USD 12 mn10.3%
15AustriaUSD 3.3 mn0.6%USD 8.9 mn10.4%
16BrazilUSD 2.7 mn0.5%USD 8.1 mn11.4%
17TaiwanUSD 2.6 mn0.5%USD 8.0 mn11.7%
18IsraelUSD 2.3 mn0.4%USD 6.2 mn10.5%
19CanadaUSD 1.9 mn0.3%USD 5.1 mn10.3%
20ItalyUSD 1.6 mn0.3%USD 4.2 mn10.2%
21SpainUSD 1.1 mn0.2%USD 3.0 mn10.4%
22AustraliaUSD 0.99 mn0.2%USD 2.6 mn10.4%
23PolandUSD 0.71 mn0.1%USD 2.2 mn11.8%
24MexicoUSD 0.66 mn0.1%USD 2.0 mn11.9%
25RussiaUSD 0.49 mn0.09%USD 1.6 mn12.2%
Rest of worldUSD 16 mn2.8%USD 41 mn10.2%
Exhibit 5United States and China account for 48% of the USD 1.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Continuous Flow Bioreactors market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 549 mn. United States: +USD 334 mn; China: +USD 146 mn; Germany: +USD 87 mn; South Korea: +USD 73 mn; Switzerland: +USD 56 mn; 20 other countries: +USD 288 mn; Rest of world: +USD 26 mn. Market value 2036: USD 1.6 bn.Market value 2026549 mnUnited States+334 mnChina+146 mnGermany+87 mnSouth Korea+73 mnSwitzerland+56 mn20 other countries+288 mnRest of world+26 mnMarket value 20361.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Sartorius
  • Cytiva
  • Thermo Fisher Scientific
  • Merck KGaA

Group 2: Regional and specialist players

  • Repligen
  • Eppendorf
  • Getinge
  • ABEC
  • Zeta Group

Group 3: Emerging and niche players

  • Applikon Biotechnology
  • PBS Biotech
  • Cellexus
  • Celltainer Biotech
  • Kuhner

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the continuous flow bioreactors market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 11.0% is calculated from the resulting values.

The market is divided by scale, by use, by format, by material, by application. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the continuous flow bioreactors market?

The global continuous flow bioreactors market is estimated at USD 490 mn in 2025 and USD 549 mn in 2026.

How fast will the continuous flow bioreactors market grow?

It is forecast to reach USD 1.6 bn by 2036, a compound annual growth rate of 11.0% from 2026, an increase of USD 1.0 bn.

Which country is the largest market for continuous flow bioreactors?

United States is the largest market by revenue at USD 198 mn in 2026, 36.0% of the global total. The three largest countries together hold 56.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 13.9% a year from 2026 to 2036.

Which continuous flow bioreactors segment is largest?

In the by scale split, Pilot and process development is the largest segment with 38.0% of 2026 revenue.

Who are the leading continuous flow bioreactors companies?

Global leaders include Sartorius, Cytiva, Thermo Fisher Scientific, Merck KGaA.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Comparator Sourcing Continuous Peripheral Nerve Block Catheter →

All Healthcare markets →

Request a sample